Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11241409rdf:typepubmed:Citationlld:pubmed
pubmed-article:11241409lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:11241409lifeskim:mentionsumls-concept:C0042172lld:lifeskim
pubmed-article:11241409lifeskim:mentionsumls-concept:C0345905lld:lifeskim
pubmed-article:11241409lifeskim:mentionsumls-concept:C0596611lld:lifeskim
pubmed-article:11241409pubmed:issue3lld:pubmed
pubmed-article:11241409pubmed:dateCreated2001-3-12lld:pubmed
pubmed-article:11241409pubmed:abstractTextDeletions or mutations of the E-cadherin gene may result in reduced cell adhesiveness. In particular, conservative point mutations within the N-terminal calcium-binding pocket (including exons 7, 8, and 9) are frequently detected in several cancers and are enough to abolish cell-cell adhesion. There have been no studies on E-cadherin gene mutations in human intrahepatic cholangiocarcinoma (ICC). Human ICCs were therefore investigated for E-cadherin gene mutations within exons 7, 8, and 9. In addition, the relationships were analysed between their mutations and the immunohistochemical expression of E-cadherin, histological grade, and clinicopathological parameters. The E-cadherin gene was analysed in 34 tumours by nested polymerase chain reaction/single-strand conformation polymorphism (PCR/SSCP) followed by DNA sequencing. In four of the 34 cases (11.8%), tumour-restricted mobility shifts were observed; two cases harboured a single shift, one case presented two different mobility shifts, and one case presented three different mobility shifts within exons 7 and 8, encoding extracellular domains of E-cadherin. Polymorphism as previously reported was not identified and all seven new DNA alterations were not present in genomic DNA of non-tumour origin. The E-cadherin gene mutations correlated significantly with down-regulated E-cadherin protein expression and high ICC histological grade. These data suggest that E-cadherin gene mutations in ICC are associated with reduced cell adhesiveness and high histological grade.lld:pubmed
pubmed-article:11241409pubmed:languageenglld:pubmed
pubmed-article:11241409pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11241409pubmed:citationSubsetIMlld:pubmed
pubmed-article:11241409pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11241409pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11241409pubmed:statusMEDLINElld:pubmed
pubmed-article:11241409pubmed:monthMarlld:pubmed
pubmed-article:11241409pubmed:issn0022-3417lld:pubmed
pubmed-article:11241409pubmed:authorpubmed-author:MiyajiSSlld:pubmed
pubmed-article:11241409pubmed:authorpubmed-author:AshidaKKlld:pubmed
pubmed-article:11241409pubmed:authorpubmed-author:TeradaTTlld:pubmed
pubmed-article:11241409pubmed:authorpubmed-author:EndoKKlld:pubmed
pubmed-article:11241409pubmed:issnTypePrintlld:pubmed
pubmed-article:11241409pubmed:volume193lld:pubmed
pubmed-article:11241409pubmed:ownerNLMlld:pubmed
pubmed-article:11241409pubmed:authorsCompleteYlld:pubmed
pubmed-article:11241409pubmed:pagination310-7lld:pubmed
pubmed-article:11241409pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:meshHeadingpubmed-meshheading:11241409...lld:pubmed
pubmed-article:11241409pubmed:year2001lld:pubmed
pubmed-article:11241409pubmed:articleTitleE-cadherin gene mutations in human intrahepatic cholangiocarcinoma.lld:pubmed
pubmed-article:11241409pubmed:affiliationSecond Department of Pathology, Tottori University, Faculty of Medicine, 86 Nishi-cho, Yonago 683-8503, Tottori, Japan.lld:pubmed
pubmed-article:11241409pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11241409lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11241409lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11241409lld:pubmed